Safety and Efficacy of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Congenital Diaphragmatic Hernia (CDH)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorDr Erin Perrone

About this trial

The purpose of the study is to determine if babies with left or right-sided CDH that undergo the FETO procedure survive more often and have fewer long-term complications than babies that have similar left or right-sided CDH that elect not to have the FETO procedure performed during pregnancy.

Eligibility criteria

Qualifiers

Provision of signed and dated informed consent form

Stated willingness to comply with all study procedures and availability (meets psychosocial criteria below) for the duration of the study

Pregnant women, age 18 years and older

Singleton pregnancy

Disqualifiers

Patient <18 years of age

Multi-fetal pregnancy

History of natural rubber latex allergy

Preterm labor, short cervix (<20mm within 24 hours of FETO balloon insertion procedure), or uterine anomaly strongly predisposing to preterm labor, placenta previa

Trial design

Treatments tested in this trial

  • FETO with Goldballoon Detachable Balloon (GOLDBAL2) along with the Delivery Microcatheter (BALTACCI-BDPE100)

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Dr Erin Perrone

Lead sponsor

University of Michigan

Sponsor institution